Glenmark Pharma Climbs After Exclusive Licensing Agreement With Menarini

On Wednesday, shares of Glenmark Pharmaceuticals Ltd rose as much as 2% to Rs 497.70 after the Mumbai-based company announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3pmKleh